Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
03.08.2007 20:31:00
|
Abbott Chief Operating Officer Richard A. Gonzalez to Retire
ABBOTT PARK, Ill., Aug. 3 /PRNewswire-FirstCall/ -- Richard A. Gonzalez, president and chief operating officer, and a member of Abbott's board of directors, plans to retire after a distinguished 30-year career with the company.
"Rick is a consummate leader and has had a distinguished career at Abbott, including his work to help conceive and execute Abbott's successful medical products strategy," said Miles D. White, chairman and chief executive officer, Abbott. "He is a close friend and colleague with whom I've worked virtually my whole career at Abbott. I thank him for his many great contributions to our company and wish him the very best in his retirement."
Gonzalez will remain with Abbott until Sept. 30, 2007. Upon his retirement, the heads of Abbott's four operating businesses -- medical devices, pharmaceuticals, nutritionals and diagnostics -- will report directly to Mr. White.
About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com/.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratoriesmehr Nachrichten
10.04.25 |
NASDAQ Composite Index-Papier Abbott Laboratories-Aktie: So viel Gewinn hätte ein Investment in Abbott Laboratories von vor 3 Jahren eingefahren (finanzen.at) | |
03.04.25 |
NASDAQ Composite Index-Wert Abbott Laboratories-Aktie: So viel Gewinn hätte ein Abbott Laboratories-Investment von vor einem Jahr abgeworfen (finanzen.at) | |
01.04.25 |
Erste Schätzungen: Abbott Laboratories gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) | |
27.03.25 |
Börse New York: S&P 500 verbucht letztendlich Verluste (finanzen.at) | |
27.03.25 |
Börse New York in Rot: NASDAQ Composite verbucht Verluste (finanzen.at) | |
27.03.25 |
Schwacher Handel: S&P 500 präsentiert sich nachmittags leichter (finanzen.at) | |
27.03.25 |
Verluste in New York: S&P 500 präsentiert sich leichter (finanzen.at) | |
27.03.25 |
NASDAQ Composite Index-Wert Abbott Laboratories-Aktie: So viel hätten Anleger an einem Abbott Laboratories-Investment von vor 10 Jahren verdient (finanzen.at) |
Analysen zu Abbott Laboratoriesmehr Analysen
Aktien in diesem Artikel
Abbott Laboratories | 112,50 | -1,32% |
|
Indizes in diesem Artikel
NASDAQ Comp. | 16 724,46 | 2,06% | |
S&P 500 | 5 363,36 | 1,81% | |
NYSE US 100 | 15 641,74 | -2,48% |